Note: Ingredients listed on restricted chemical lists
EC/CAS
71751-41-2
Name of the chemical
Abamectin (Kombination von Abamectin B1a und Abamectin B1b) (ISO); Abamectin B1a (Reinheit ≥ 80 %) (618/2012)
Concentration
N/A
EC/CAS
872-50-4
Name of the chemical
N-Methyl-2-Pyrrolidone; 1-methyl-2-pyrrolidone (NMP)
Concentration
N/A
General Information
Revision date
2010-09-02
Product name
Genfarm Aba 18 Miticide/Insecticide
1.2.1 Relevant identified uses
Agricultural miticide and insecticide for use as described on the product label
Icons in SDS
Company Information
company name
Landmark Operations Limited
Section 2
Hazard statements
This product is classified as: Hazardous according to the criteria of SWA Australia. Dangerous according to the Australian Dangerous Goods (ADG) Code. R39/23/25, R36/38, R50/53. Toxic danger of very serious irreversible effects through inhalation and if swallowed. Irritating to eyes and skin. Very toxic to aquatic organisms, may cause long-term adverse effects to the aquatic environment.
Precautionary statements
S20, S29, S38, S61, S24/25. When using, do not eat or drink. Do not empty into drains. In case of insufficient ventilation, wear suitable respiratory equipment. Avoid release to the environment. Refer to special instructions/Safety Data Sheets. Avoid contact with skin and eyes.
SUSMP Classification
S6
ADG classification
Class 6.1 Toxic substances
UN Number
2902, PESTICIDE, LIQUID, TOXIC, N.O.S Emergency Overview Physical Description & colour: Colourless to yellow liquid. Odour: Characteristic odour.
Health hazards
Symptoms of poisoning observed in laboratory animals include pupil dilation, vomiting, convulsions and/or tremors, and coma. Abamectin acts on insects by interfering with the nervous system. At very high doses, it can affect mammals, causing symptoms of nervous system depression such as incoordination, tremors, lethargy, excitation, and pupil dilation. Very high doses have caused death from respiratory failure. Abamectin is not readily absorbed through skin. May cause very serious irreversible effects, toxic by inhalation and if swallowed, irritating to eyes and skin.
Potential health effects
See section 11 for long term effects Inhalation Short term exposure: Significant inhalation exposure is considered to be unlikely. Available data shows that this product is toxic, see symptoms above. Skin Contact: Short term exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. However product is a skin irritant. Symptoms may include itchiness and reddening of contacted skin. Other symptoms may also become evident, but all should disappear once exposure has ceased. Eye Contact: Short term exposure: Exposure via eyes is considered to be unlikely. This product is an eye irritant. Symptoms may include stinging and reddening of eyes and watering which may become copious. Other symptoms may also become evident. If exposure is brief, symptoms should disappear once exposure has ceased. However, lengthy exposure or delayed treatment may cause permanent damage. Ingestion: Short term exposure: Significant oral exposure is considered to be unlikely. Available data shows that this product is toxic, see symptoms above. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC.